KS
Koji Sasaki
Hematology & Oncology
Credentials: · · · · ·
History
Research
Ibrutinib and Venetoclax for First-Line Treatment of CLL
New England Journal of Medicine · 2019 · 426 citations
Nature Medicine · 2023 · 334 citations
Journal of Clinical Oncology · 2021 · 294 citations

229 papers

197 papers

190 papers

177 papers

153 papers · 16 as a fellow

152 papers

145 papers
- GB
135 papers
Clinical trials
- 2005–2030
Principal investigator · Recruiting
M.D. Anderson Cancer Center




